Skip to main content

GT’s Ginger Pigott and Roman Fayerberg to Speak at DeviceTalks West

LOS ANGELES – Dec. 10, 2018 – Shareholders Ginger Pigott and Roman Fayerberg of global law firm Greenberg Traurig, LLP are speaking at the DeviceTalks West conference Dec. 11. The conference will be held Dec. 11-12 in Costa Mesa, California, at the Hilton Orange County/Costa Mesa. The firm is a sponsor of the conference.

The DeviceTalks West conference will feature leaders in the medical device industry who will give insights and “explore the latest technologies and trends shaping the medical device industry.” Pigott and Fayerberg will speak on the “Hot Topics: M&A Megadeals, IP, Financing, and Products Liability Trends Impacting MedTech” panel.

Pigott practices in the firm’s Los Angeles office and serves as vice chair of the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice. She focuses her practice on products liability litigation with an emphasis on the defense of complex medical device and pharmaceutical products. Pigott handles high-stakes, single-plaintiff cases and complex litigation, including multidistrict litigation, coordinated state actions and class actions working as both national and regional counsel.

Fayerberg practices in the firm’s Boston office and is a registered patent attorney. He focuses his practice on the development and management of strategic patent portfolios and counseling clients on patent issues, primarily in technologies related to medical devices, drug delivery systems, biodegradable polymers and films, and coating formulations for medical devices and other commercial applications. Fayerberg also advises clients on intellectual property due diligence investigations for venture capital investment, mergers and acquisitions, and licensing opportunities.

About Greenberg Traurig’s Pharmaceutical, Medical Device & Health Care Litigation Practice: The Pharmaceutical, Medical Device & Health Care Litigation Practice is an integral part of the firm’s 600-plus member national Litigation Practice. The team is nationally recognized for its dynamic courtroom presence, responsiveness to clients, and deep subject matter knowledge. Recent recognitions include national rankings for 2018 “Products Liability & Mass Torts” from Chambers USA Guide; national rankings for 2018 “Practice Liability & Mass Torts Defense: Pharmaceuticals and Medical Devices” from The Legal 500 United States; and being named the Products Liability/Mass Torts Litigation Department of the Year by The Daily Report in 2013 and from 2015 - 2017. In addition, Greenberg Traurig is recognized as a "Product Liability Litigation Standout" in the BTI Litigation Outlook 2018 published by BTI Consulting Group.

About Greenberg Traurig’s Intellectual Property & Technology Practice: With more than 180 intellectual property attorneys and agents in the United States, Asia, and Europe, Greenberg Traurig provides a broad range of patent, trademark and copyright protection and strategic counseling. Greenberg Traurig was named a “National Tier 1” Law Firm for IP Litigation, Patent Law, Trademark and Information Technology Law by U.S. News and Best Lawyers, 2017 “Best Law Firms Rankings."

About Greenberg Traurig: Greenberg Traurig, LLP (GT) has more than 2,000 attorneys in 38 offices in the United States, Latin America, Europe, Asia and the Middle East. GT has been recognized for its philanthropic giving, was named the largest firm in the U.S. by Law360 in 2017, and is among the Top 20 on the 2018 Am Law Global 100. Web: Twitter: @GT_Law.